In the current study, we verified that CTR1 knockdown inhibited Pt and DNA-Pt adduct accumulation in NSCLC cells, whereas EGCG treatment enhanced this accumulation. The gene discussed is SLC31A1; the disease is non-small cell lung carcinoma.